Who is sponsoring NCT04177979?

NCT04177979 is sponsored by Sulaiman AlRajhi Colleges.

What drugs are being tested in NCT04177979?

Interventions in NCT04177979: Near-assisted learning through trained peers.

What condition does NCT04177979 study?

NCT04177979 studies Cost, Problem-based Learning, Peer Group.

Is NCT04177979 still recruiting?

NCT04177979 is currently completed. Last updated 26 November 2019.

Last reviewed 2019-11-26 · How we verify

NCT04177979: SRMC

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Efficacy of Near-Assisted Learning (NAL) in Improving Students' Objective Structured Clinical Examination (OSCE) Grades

Completed NA Last updated 26 November 2019

What this trial tests

NA trial testing Near-assisted learning through trained peers in Cost in 48 participants. Completed in 30 April 2019.

Timeline

6 April 2019

Primary endpoint
30 April 2019

30 April 2019

Quick facts

Lead sponsor	Sulaiman AlRajhi Colleges
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	other
Enrollment	48
Start date	6 April 2019
Primary completion	30 April 2019
Estimated completion	30 April 2019
Sites	1 location across Saudi Arabia

Drugs / interventions tested

Near-assisted learning through trained peers

Conditions studied

Cost — all drugs for Cost →
Problem-based Learning — all drugs for Problem-based Learning →
Peer Group — all drugs for Peer Group →

Sponsor

Sulaiman AlRajhi Colleges

Who can join

Eligibility, male only, with Cost or Problem-based Learning. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to evaluate the impact of near-assisted learning (NAL) on first-year medical students' objective structured clinical examination (OSCE) grades in a problem-based learning (PBL) environment.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Sulaiman AlRajhi Colleges trials

Trials by the same sponsor.

NCT04332562 — The Association Between Serum β-hydroxybutyrate and Levels of Systemic Hypertension · NA · unknown
NCT03804801 — Effect of Hibiscus Sabdariffa on Blood Pressure in a University Population · Phase 4 · unknown
NCT03781557 — Effects of Omega-3 Fatty Acids Supplement in Cognition of Young Healthy Adults and in Their Reaction Time of Computerize · Phase 4 · unknown
NCT03447301 — The Effect of Daily Consumption of Extra Virgin Olive Oil on Blood Glucose Among Diabetic Patients · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04177979 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sulaiman AlRajhi Colleges
Last refreshed: 26 November 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04177979.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing